Empagliflozin induced euglycemic diabetic ketoacidosis in a patient undergoing coronary artery bypass graft despite discontinuation of the drug 48 hours prior to the surgery
2021 ◽
Vol 15
(3)
◽
pp. 909-911
2006 ◽
Vol 2006
◽
pp. 49-50
2006 ◽
Vol 55
(5)
◽
pp. 451
2019 ◽
Vol 31
(3)
◽
pp. 197-216
Keyword(s):